January 26, 2015 8:43 PM ET


Company Overview of VGX Pharmaceuticals, LLC

Company Overview

VGX Pharmaceuticals, LLC, a biopharmaceutical company, discovers and develops vaccines and therapies for infectious diseases and cancers. The company’s phase I clinical product portfolio comprises PENNVAX-B, a DNA vaccine for the prevention of HIV; VGX-3100, a therapeutic DNA vaccine for cervical cancer; and the CELLECTRA electroporation DNA delivery device. It also develops VGX-1027, a small molecule drug in phase I clinical study for inflammatory diseases; and VGX-3400, a preventative DNA vaccine for avian influenza. The company was founded in 2000 and is headquartered in Blue Bell, Pennsylvania. VGX Pharmaceuticals, LLC was formerly known as VGX Pharmaceuticals, Inc. As a result of the a...

450 Sentry Parkway

Blue Bell, PA 19422

United States

Founded in 2000





Key Executives for VGX Pharmaceuticals, LLC

Co-Founder and Chairman of Scientific Advisory Board
Chief Financial Officer
Vice President and General Counsel
Age: 50
Vice President of Asian Operations
Vice President of Research
Compensation as of Fiscal Year 2014.

Similar Private Companies By Industry

Company Name Region
Ardent Pharmaceuticals, Inc. United States
Araxes Pharma, LLC United States
VersaPharm Incorporated United States
Adventure Options, Inc. United States
Millennium Pharmaceuticals, Inc. United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Rush University United States
Greater Houston Partnership United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact VGX Pharmaceuticals, LLC, please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.